Drug Industry

Order of the National Green Tribunal regarding an illegal cracker unit in Thanjavur district, Tamil Nadu, 29/05/2025

Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …

Prices, costs, and affordability of new medicines for Hepatitis C in 30 countries: An economic analysis

New hepatitis C virus (HCV) medicines have markedly improved treatment efficacy and regimen tolerability. However, their high prices have limited access, prompting wide debate about fair and affordable prices. This study systematically compared the price and affordability of sofosbuvir and ledipasvir/sofosbuvir across 30 countries to assess affordability to health systems …

Society must seize control of the antibiotics crisis

What are we to do about antibiotic resistance? Last week, another government report repeated stark warnings about the crisis, and offered some suggestions to improve the situation. The UK report, prepared by a panel chaired by the economist Jim O'Neill, naturally focused on financial incentives, including US$1-billion prizes for pharmaceutical …

Health Ministry panel rejects Sanofi's clinical waiver plea for dengue vaccine

French drug and vaccines giant Sanofi suffered a setback in introducing its muchawaited dengue vaccine Dengvaxia in India after a top health ministry committee rejected its request to waive additional clinical studies. The decision of the apex committee is expected to delay the entry of the vaccine, which has been …

New Policy on Anvil to Check Pollution in Pharmaceutical Units

VISAKHAPATNAM: The government is planning to introduce a new policy to ensure better coordination between the APPCB and pharma companies to bring down pollution levels, said Andhra Pradesh Pollution Control Board chairman GN Phani Kumar. He was speaking at the Environment Clinic, an interaction meet between the APPCB and pharma …

Seeing like an Indian generic pharmaceutical company - Generics as humanitarian goods in Africa

After 2010, two Indian generic companies started local plants in South Africa, attempted to partake in the morally loaded politics of antiretroviral therapy, and complied with broader affirmative action policies there. This article analyses a variety of sources and tries to lay bare the nexus between drug manufacturers, the state, …

Light can help develop new materials for environment protection

Light can put active materials into motion and humans can use this movement for development of new programmable materials which can be used for environment protection and deliver pharmaceutical substances, a study said. Light of a certain wavelength can be used to put so-called active materials into motion and control …

Light can help develop new materials for environment protection

Light can put active materials into motion and humans can use this movement for development of new programmable materials which can be used for environment protection and deliver pharmaceutical substances, a study said. Light of a certain wavelength can be used to put so-called active materials into motion and control …

Cleaning up the pharma industry - A landmark ban on irrational drugs

For over 30 years pharmaceutical companies have been selling fixed-dose combination drugs with scant need to justify their efficacy, safety or rationality for use. The Government of India has finally banned 344 such drugs, though pharma companies have been able to obtain interim judicial stay orders. It is hoped that …

Miracle drug' for resistant TB to be rolled out for trial today

A `miracle drug' to bat tle multi-drug resist ant tuberculosis MDR-TB, and extensivelydrug resistant TB (XDRTB), will be rolled out on Monday in six public hospitals across the country. This is part of a co-ordinated programme between the government and Johnson & Johnson, whose pharma arm Janssen has manufactured the …

Budget disappoints health players

Many in the healthcare sector were disappointed by the Union Budget. "In comparison to previous years, the 2016 Union Budget seemed lacklustre in terms of the health care sector. Healthcare being one of the major concerns in the country, a lesser amount of focus was given to the development of …

Govt draws thin red line to curb antibiotics misuse

To check irrational use of antibiotics, packs of certain medicines will soon carry a 'red line' differentiating them from other drugs. The move is aimed at discouraging unnecessary prescription and over-the-counter sale of antibiotics causing drug resistance for several critical diseases including TB, malaria, urinary tract infection and even HIV. …

World's first Dengue vaccine out

Dengue is one of the most devastating mosquito borne diseases in the world. Plaguing mostly the developing countries, Dengue is a health hazard that takes scores of lives every year. Asian countries spend an estimated 6.5 billion USD annually in both direct and indirect medical costs due to Dengue. The …

Health Dept asked to clear medical waste from Kadamba plateau

As dumping and burning of around 200 kg of bio-medical waste has led to environmental pollution at Kadamba Plateau, Goa State Pollution Control Board (GSPCB) has directed the Health Department to collect and dispose the waste at the earliest, failing which legal action will be initiated. Following complaints from locals, …

Clinical trials weapon of last resort in cancer battle

Having exhausted all treatment options, some cancer patients are seeking to undergo clinical trials ast Friday, Ashok (name changed), an accountant, went through the morning ritual: bath, a dab of his favourite perfume, a bright blue T-shirt and a smile. Nothing out of the ordinary, except that he felt the …

JB Chemicals to file review plea in NGT against plant closure

JB Chemicals & Pharmaceuticals today said it will file a review petition before the National Green Tribunal (NGT) after the Supreme Court stayed the direction issued by the Tribunal for closure of its bulk drugs plant in Gujarat. The Supreme Court has also directed the drug firm to file a …

Indian firm develops ‘world’s first’ Zika virus vaccine

In a major breakthrough, Hyderabad-based biotechnology research company Bharat Biotech has announced that it has developed the world’s first vaccine for Zika virus. The company has submitted two vaccine candidates — one inactivated and one recombinant — to the Government of India and is waiting for regulatory approvals to produce …

Impacts of pharmaceutical pollution on communities and environment in India

Swedish financial services group Nordea, in a report following its investigation on pharma pollution in Hyderabad and Visakhapatnam, severely criticised pharma companies and the Pollution Control Boards (PCB) of both states for wreaking environmental havoc in the two cities. The report blamed the PCBs of both states as, “highly corrupt” …

Pharmaceutical industry off-label promotion and self-regulation: A document analysis of off-label promotion rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003–2012

European Union law prohibits companies from marketing drugs off-label. In the United Kingdom—as in some other European countries, but unlike the United States—industry self-regulatory bodies are tasked with supervising compliance with marketing rules. The objectives of this study were to (1) characterize off-label promotion rulings in the UK compared to …

India’s intellectual property-based biomedical start-ups

I have posed 50 questions each to the founders of 50 young Indian biomedical firms that are less than 5 years old. The questions were on the following themes: the backgrounds of the founders and their employees, the area of work of the company, its location and incubation experience, its …

Implementation of the malaria candidate vaccine RTS,S/AS01

As vaccine manufacturers tackle increasingly intractable pathogens, vaccines will be developed that show efficacy, but that are less efficacious than established vaccines. Consequently, regulatory and public health authorities will be faced with difficult decisions about whether such vaccines should be recommended for implementation and, if so, under what circumstances. The …

  1. 1
  2. ...
  3. 5
  4. 6
  5. 7
  6. 8
  7. 9
  8. ...
  9. 73

IEP child categories loading...